These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. 3-substituted-1,2-benzisoxazoles: novel antipsychotic agents. Davis L; Effland RC; Klein JT; Dunn RW; Geyer HM; Petko WW Drug Des Discov; 1992 Feb; 8(3):225-40. PubMed ID: 1356026 [TBL] [Abstract][Full Text] [Related]
6. [The search of small molecules with antipsychotic activity on the background of neurotensin]. Ostrovskaia RU; Gudasheva TA; Krupina NA; Seredin SB Bioorg Khim; 2012; 38(1):119-26. PubMed ID: 22792715 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues. Hadden MK; Orwig KS; Kokko KP; Mazella J; Dix TA Neuropharmacology; 2005 Dec; 49(8):1149-59. PubMed ID: 16095636 [TBL] [Abstract][Full Text] [Related]
8. [Neurotensine dipeptide analog dilept decreases the deficiency of prestimulus startle reflex inhibition: a prognostic sign of antipsychotic activity]. Ostrovskaia RU; Krupina NA; Gudasheva TA; Voronina TA; Seredenin SB Eksp Klin Farmakol; 2009; 72(5):3-7. PubMed ID: 19928566 [TBL] [Abstract][Full Text] [Related]
9. [Decrease in the glutamate release may contribute to the neuroprotective action of the novel neuroleptic drug dilept]. Us KS; Klodt PM; Kudrin VS; Arkhipenko NV; Gudasheva TA; Ostrovskaia RU Eksp Klin Farmakol; 2007; 70(3):3-5. PubMed ID: 17650623 [TBL] [Abstract][Full Text] [Related]
10. Comparison of antipsychotic activity and discriminative stimulus effects of the novel acylprolyltyrosine containing compound, GZR-123, and sulpiride. Asmakova LS; Kalinina TS; Ostrovskaya RU; Gudasheva TA; Zaitseva NI; Bondarenko NA; Voronina TA; Seredenin SB Pharmacol Biochem Behav; 1999 Oct; 64(2):359-62. PubMed ID: 10515313 [TBL] [Abstract][Full Text] [Related]
12. 6-(alkylamino)-9-alkylpurines. A new class of potential antipsychotic agents. Kelley JL; Bullock RM; Krochmal MP; McLean EW; Linn JA; Durcan MJ; Cooper BR J Med Chem; 1997 Sep; 40(20):3207-16. PubMed ID: 9379440 [TBL] [Abstract][Full Text] [Related]
13. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice. Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157 [TBL] [Abstract][Full Text] [Related]
14. [The new tripeptoid neurotensin analog dilept selectively affects dopamine turnover in nucleus accumbens and hypothalamus]. Retiunskaia MV; Kudrin VS; Klodt PM; Us KS; Gudasheva TA; Ostrovskaia RU Eksp Klin Farmakol; 2005; 68(6):15-8. PubMed ID: 16405028 [TBL] [Abstract][Full Text] [Related]
15. Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist. Feifel D; Reza TL; Wustrow DJ; Davis MD J Pharmacol Exp Ther; 1999 Feb; 288(2):710-3. PubMed ID: 9918579 [TBL] [Abstract][Full Text] [Related]
16. New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation. Liao Y; Venhuis BJ; Rodenhuis N; Timmerman W; Wikström H; Meier E; Bartoszyk GD; Böttcher H; Seyfried CA; Sundell S J Med Chem; 1999 Jun; 42(12):2235-44. PubMed ID: 10377229 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, structure-activity relationships, and biological characterization of novel arylalkoxyphenylalkylamine sigma ligands as potential antipsychotic drugs. Nakazato A; Ohta K; Sekiguchi Y; Okuyama S; Chaki S; Kawashima Y; Hatayama K J Med Chem; 1999 Mar; 42(6):1076-87. PubMed ID: 10090790 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological investigations of new 6-oxo-1,2,3,4-tetrahydro-6H-pyrimido[2,1-b]quinazoline derivatives. Korzycka L; Szadowska A; Pakulska W Pharmazie; 1994 Nov; 49(11):815-9. PubMed ID: 7838867 [TBL] [Abstract][Full Text] [Related]